JUBLPHARMA — Jubilant Pharmova Balance Sheet
0.000.00%
- IN₹167.42bn
- IN₹187.96bn
- IN₹72.35bn
- 77
- 23
- 95
- 76
Annual balance sheet for Jubilant Pharmova, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6,611 | 9,803 | 10,108 | 9,539 | 10,862 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10,313 | 11,469 | 12,125 | 12,709 | 11,537 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 29,525 | 35,092 | 37,624 | 38,761 | 35,772 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 25,752 | 27,911 | 33,651 | 36,871 | 51,682 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 89,181 | 99,909 | 111,566 | 115,485 | 127,564 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 10,488 | 15,916 | 17,724 | 18,890 | 21,646 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 41,766 | 46,723 | 57,574 | 61,146 | 65,015 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 47,415 | 53,186 | 53,993 | 54,339 | 62,549 |
| Total Liabilities & Shareholders' Equity | 89,181 | 99,909 | 111,566 | 115,485 | 127,564 |
| Total Common Shares Outstanding |